|The TCR, gamma, delta n/a (Catalog #MBS609736) is an Antibody produced from Hamster and is intended for research purposes only. The product is available for immediate purchase. The TCR, gamma, delta (T Cell Receptor) (FITC) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s TCR, gamma, delta can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).
Flow Cytometry: Neat, Optimal working dilutions to be determined by researcher.
Flow Cytometry: Use 10ul of the suggested working dilution to label 1 x10e6 cells in 100ul. Researchers should empirically determine the suitability of the TCR, gamma, delta n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TCR, gamma, delta n/a product has the following accession number(s) (GI #4454233) (NCBI Accession #CAA10784.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: C57BL/6J intra epithelial lymphocytes.
Recommended Negative Controls: Hamster IgG Negative Control: FITC. Fusion Partners: Spleen cells from an immunized Armenian hamster were fused with cells of the murine myeloma SP2/0 myeloma cell line. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TCR, gamma, delta are readily searchable from our website. Different antibodies against the same target such as TCR, gamma, delta may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.